About Molecular Docking & Virtual Screening
Molecular Docking & Virtual Screening tools sit at the point where target structures, compound libraries, and compute budgets collide. Medicinal chemists and computational scientists use them to prioritise which molecules ever reach an assay, working under constraints that include uncertain scoring function accuracy, receptor flexibility, ligand protonation and tautomer choices, and library sizes that now routinely reach the billions. Procurement decisions in this category are shaped less by interface polish than by throughput at scale, integration with library preparation and downstream free-energy or ADMET pipelines, and licensing terms tied to commercial use of scoring functions and curated chemical libraries.
Two patterns stand out across the category. First, AI and ML methods now appear in roughly 60% of available platforms, reflecting the shift toward learned scoring functions, pose prediction networks, and active-learning loops that make ultra-large library screens tractable. Second, deployment skews toward cloud and hybrid models, with on-premise still holding around 30% of the field — a reasonable split given that screening workloads benefit from elastic GPU capacity while target structures and proprietary libraries often carry data-residency constraints. Formal compliance certifications remain rare here, with ISO 27001 present in only a small fraction of listings.
Browse Molecular Docking Software
Molecular docking and protein binding modeling through conversational AI, with data gathering from chemical databases and AI-predicted properties.
3D ligand- and structure-based drug design with conformer generation, docking, virtual screening, and binding affinity prediction for small molecules to macrocycles.
Ligand-based virtual screening to rapidly identify diverse hits from millions of compounds, reducing wet-lab screening costs.
Scalable computational drug discovery with AI and physics-driven molecular insights, cheminformatics automation, and collaborative workflows.
High-throughput combinatorial docking and virtual screening for ultra-large chemical libraries using GPU-accelerated anchor-based expansion.
Molecular docking, pocket identification, and ADMET prediction via API for custom drug discovery workflows.
Drug Discovery Solutions (ALScreen, PELETac)
AI and molecular modeling for multi-stage drug discovery, from target selection and hit finding through lead optimization and targeted protein degradation.
Ligand- and structure-based design for small molecule discovery, with AI-assisted generation, binding affinity prediction, and molecular dynamics simulation.
Binding affinity prediction for lead discovery and optimization, reducing experimental validation needs in drug discovery.
Structure-based drug design, virtual library design, and metabolic liability prediction for preclinical drug discovery.
Common Questions About Molecular Docking & Virtual Screening
Companies with the largest Molecular Docking software portfolios
Molsoft
- Physics-based and AI technologies for molecular modeling, virtual screening, and drug design.
Cresset
- AI-enriched computational chemistry for molecular design, binding affinity prediction, and lead optimization in drug discovery.
OpenEye
- Physics-based molecular modeling and virtual screening for hit identification, lead optimization, and free energy predictions in drug discovery.